Skip Nav Destination
Close
Article navigation
July 2002
- Cover Image
- PDF Icon PDF LinkTable of Contents
Conference Abstract|
July 01 2002
CD98 and Galectin-3 Expression in Lung Cancer
RC Buttery
;
RC Buttery
1Rayne Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, EH8 9AG.
Search for other works by this author on:
H Monaghan
;
H Monaghan
1Rayne Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, EH8 9AG.
Search for other works by this author on:
DM Salter
;
DM Salter
1Rayne Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, EH8 9AG.
Search for other works by this author on:
C Haslett
;
C Haslett
1Rayne Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, EH8 9AG.
Search for other works by this author on:
T Sethi
T Sethi
1Rayne Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, EH8 9AG.
Search for other works by this author on:
Clin Sci (Lond) (2002) 103 (s47): 54P.
Citation
RC Buttery, H Monaghan, DM Salter, C Haslett, T Sethi; CD98 and Galectin-3 Expression in Lung Cancer. Clin Sci (Lond) 1 July 2002; 103 (s47): 54P. doi: https://doi.org/10.1042/cs103054Pa
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
1
Views
0
Citations
Cited By
Related Articles
Drosophila expresses a CD98 transporter with an evolutionarily conserved structure and amino acid-transport properties
Biochem J (May,2009)
Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling
Biochem J (May,2004)